PDS Biotechnology
PDSB
PDSB
46 hedge funds and large institutions have $82.4M invested in PDS Biotechnology in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
7.85% more ownership
Funds ownership: 14.13% → 21.98% (+7.8%)
30% less call options, than puts
Call options by funds: $2.75M | Put options by funds: $3.9M
Holders
46
Holding in Top 10
2
Calls
$2.75M
Puts
$3.9M
Top Buyers
| 1 | +$11.7M | |
| 2 | +$2.8M | |
| 3 | +$2.72M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$2.18M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
+$1.47M |
Top Sellers
| 1 | -$1.75M | |
| 2 | -$1.66M | |
| 3 | -$207K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$201K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$195K |